(Q37797743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Erythropoietin for the treatment of subarachnoid hemorrhage: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

subarachnoid hemorrhage

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Charles J. Prestigiacomo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Antonios Mammis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

500-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin receptor mRNA expression in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

The non-haematopoietic biological effects of erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Emerging biological roles for erythropoietin in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

The pleiotropic effects of erythropoietin in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Mechanisms of early brain injury after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin improves functional and histological outcome in neonatal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

NMR structure of human erythropoietin and a comparison with its receptor bound conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Production and processing of erythropoietin receptor transcripts in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Angiogenesis and plasticity: role of erythropoietin in vascular systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Expression of erythropoietin by the human placenta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Efficacy and safety of epoetin alfa in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Localization of specific erythropoietin binding sites in defined areas of the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Therapeutic approaches to vasospasm in subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin therapy for acute stroke is both safe and beneficial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Update on subarachnoid haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Hemostasis in spontaneous subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

The critical first minutes after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Cerebral vasospasm: looking beyond vasoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin and erythropoietin receptor in the developing human central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin is present in the cerebrospinal fluid of neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Origin and fate of erythropoietin in human milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Antioxidative effects of erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Epididymis is a novel site of erythropoietin production in mouse reproductive organs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Controversies in the surgical treatment of ruptured intracranial aneurysms: the First Annual J. Lawrence Pool Memorial Research Symposium--controversies in the management of cerebral aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Effects of erythropoietin on neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Carbamylated erythropoietin to treat neuronal injury: new development strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Survival of hippocampal neurons in culture upon hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Beneficial effect of erythropoietin on experimental allergic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Regulated human erythropoietin receptor expression in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin expression in primary rat Sertoli and peritubular myoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Raves and risks for erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin as a neuroprotective agent in traumatic brain injury Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin gene expression in human, monkey and murine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Safety of high-dose recombinant erythropoietin in a neonatal rat model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Role of erythropoietin in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Molecular mechanisms of early brain injury after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Hemostasis and fibrinolysis activation after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Coagulation abnormalities following primary intracerebral hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin induces changes in gene expression in PC-12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

In vivo evidence that erythropoietin protects neurons from ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Detecting and treating microvascular ischemia after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Acute microvascular platelet aggregation after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Aneurysmal subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Erythropoietin-dependent erythropoiesis: New insights and questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.026

10.1016/J.WNEU.2010.02.026

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20920933%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference